Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Electronic applications for the CFQ-R scoring

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Validation of the IPF-specific version of St. George's Respiratory Questionnaire

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Risk factors for diagnostic delay in idiopathic pulmonary fibrosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Prevalence and course of disease after lung resection in primary ciliary dyskinesia: a cohort & nested case-control study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. The impact of chest computed tomography and chest radiography on clinical management of cystic fibrosis lung disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Interstitial lung abnormalities in people with HIV infection and uninfected controls

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Patient reported outcomes (PROs) have become widely accepted outcome measures in cystic fibrosis (CF) and other respiratory diseases. The Cystic Fibrosis-Questionnaire-Revised (CFQ-R) is the best validated and most widely used PRO for CF. Data collection can be time-intensive, and electronic platforms would greatly facilitate the feasibility, utility and accuracy of administration of the CFQ-R. Given that the CFQ-R is utilized in virtually all clinical trials worldwide and is increasingly integrated into clinical practice, we developed a software application that will help users to administer, score and save CFQ-R data for all versions. All codes are open access, which will enable other PRO users to design similar applications for other respiratory diseases, such as primary ciliary dyskinesia and non-CF bronchiectasis.

Original languageEnglish
JournalRespiratory Research
Volume18
Issue number1
Pages (from-to)e108
ISSN1465-9921
DOIs
Publication statusPublished - 30 May 2017

    Research areas

  • Letter

ID: 52170080